What is the CAPS-3 study?
CAPS-3 stands for Cancer of the Pancreas Screening. One of the goals of the study is to find the best and most sensitive screening modality (CT, MRI, EUS) for small pre-cancerous pancreatic lesions, and to treat these small lesions before they turn into cancer. Another study goal is to search for a gene mutation, or chemical markers that can be linked with the development of pancreatic cancer. This study will screen the pancreas before there are any signs or symptoms of the disease. Currently, routine medical screening and testing for pancreatic cancer is not recommended for people who do not have symptoms or signs of pancreatic cancer.
